Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives.

Jpn J Clin Oncol · 2021 · PMC8326384 · PMID 34038547

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

A subgroup analysis for midgut NETs also showed a favorable trend in the everolimus arm (median PFS, 8.11 vs. 1.94 months; HR, 0.27; 95% CI, 0.15–0.51) ( 41 ).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.